BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maffeis V, Cappellesso R, Zanon A, Cazzador D, Emanuelli E, Martini A, Fassina A. HER2 status in sinonasal intestinal-type adenocarcinoma. Pathol Res Pract 2019;215:152432. [PMID: 31047725 DOI: 10.1016/j.prp.2019.04.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ferrari M, Bossi P, Mattavelli D, Ardighieri L, Nicolai P. Management of sinonasal adenocarcinomas with anterior skull base extension. J Neurooncol 2020;150:405-17. [PMID: 31897925 DOI: 10.1007/s11060-019-03385-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Maffeis V, Cappellesso R, Galuppini F, Guzzardo V, Zanon A, Cazzador D, Emanuelli E, Ventura L, Martini A, Fassina A. Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition. Virchows Arch 2020;477:241-8. [PMID: 31980958 DOI: 10.1007/s00428-020-02748-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Lechner M, Liu J, Lund VJ. Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside. Curr Oncol Rep 2020;22:106. [PMID: 32725435 DOI: 10.1007/s11912-020-00947-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]